These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3201861)

  • 1. Nuclear DNA content and prognosis in Hürthle cell tumours of the thyroid gland.
    Wallin G; Bäckdahl M; Lundell G; Auer G; Löwhagen T
    Acta Chir Scand; 1988 Sep; 154(9):501-4. PubMed ID: 3201861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of nuclear DNA content in follicular thyroid tumours.
    Bäckdahl M; Auer G; Forsslund G; Granberg PO; Hamberger B; Lundell G; Löwhagen T; Zetterberg A
    Acta Chir Scand; 1986 Jan; 152():1-7. PubMed ID: 3953203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
    Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
    Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DNA cytophotometry of oxyphilic thyroid tumors].
    Pilch H; Back W; Winter J
    Zentralbl Pathol; 1994 Feb; 139(6):433-6. PubMed ID: 8161492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical meaning of DNA content in the long term behaviour of follicular thyroid tumours: a 12-year follow up.
    Lukács GL; Balázs G; Zs-Nagy I; Mikó T
    Eur J Surg; 1994 Aug; 160(8):417-23. PubMed ID: 7811827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicular or Hürthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy?
    McHenry CR; Thomas SR; Slusarczyk SJ; Khiyami A
    Surgery; 1999 Oct; 126(4):798-802; discussion 802-4. PubMed ID: 10520931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochemical assessments of the nuclear DNA distribution pattern by means of image and flow cytometry in thyroid neoplasms and in non-neoplastic thyroid lesions. A comparative methodological study.
    Wallin G; Askensten U; Bäckdahl M; Grimelius L; Lundell G; Auer G
    Acta Chir Scand; 1989; 155(4-5):251-8. PubMed ID: 2800873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region.
    Onaran Y; Tezelman S; Gürel N; Terzioğlu T; Oğuz H; Tanakol R; Kapran Y
    Acta Chir Belg; 1999 Feb; 99(1):30-5. PubMed ID: 10090961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hürthle cell lesions in thyroid neoplasms.
    Khan MS; al-Manee MS; Huzaimeh IA; Ahmad MS
    Int Surg; 1989; 74(4):261-6. PubMed ID: 2625402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma.
    Mai KT; Khanna P; Yazdi HM; Perkins DG; Veinot JP; Thomas J; Lamba M; Nair BD
    Pathology; 2002 Jun; 34(3):239-44. PubMed ID: 12109784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hürthle cell tumors of the thyroid gland.
    Heppe H; Armin A; Calandra DB; Lawrence AM; Paloyan E
    Surgery; 1985 Dec; 98(6):1162-5. PubMed ID: 4071391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experience in Hurthle cell tumors].
    Francomano F; Napolitano L; Scipione P; Savini F; Bajocchi G; Angelucci D
    G Chir; 1998; 19(11-12):449-52. PubMed ID: 9882947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
    Elliott DD; Pitman MB; Bloom L; Faquin WC
    Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hürthle cell tumors: a twenty-five-year experience.
    Arganini M; Behar R; Wu TC; Straus F; McCormick M; DeGroot LJ; Kaplan EL
    Surgery; 1986 Dec; 100(6):1108-15. PubMed ID: 3787466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hurthle cell neoplasm of the thyroid gland.
    Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
    ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear DNA measurements in follicular thyroid adenomas.
    Bäckdahl M; Wallin G; Askensten U; Auer G; Grimelius L; Löwhagen T
    Eur J Surg Oncol; 1989 Apr; 15(2):125-9. PubMed ID: 2703057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of accordance between cytological and histopathological findings in selected thyroid tumors].
    Gołkowski F; Jabrocka A; Huszno B; Trofimiuk M; Buziak-Bereza M; Kulig J; Cichoń S
    Przegl Lek; 2004; 61(1):10-2. PubMed ID: 15230098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and histological differences in anaplastic thyroid carcinoma.
    Rodriguez JM; Piñero A; Ortiz S; Moreno A; Sola J; Soria T; Robles R; Parrilla P
    Eur J Surg; 2000 Jan; 166(1):34-8. PubMed ID: 10688214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic significance of nuclear DNA content in highly malignant thyroid tumors].
    Lukács G; Balázs G; Zs-Nagy I; Juhász F
    Wien Klin Wochenschr; 1990 Apr; 102(9):253-6. PubMed ID: 2375112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.